TAP2 is a gene, located between HLA-DP and HLA-DQ, whose products form
a transporter molecule involved in endogenous antigen processing. Pol
ymorphic residues have been described in this gene. TAP2 is of particu
lar interest because its involvement in antigen presentation makes it
a candidate for a disease susceptibility gene. In psoriasis, two clini
cal subtypes analogous to the situation in diabetes type I with early
onset and family history and type II with later onset and without fami
ly history have been described. We have previously shown that type I b
ut not type II psoriasis is associated with the HLA-DRB10701/2, -DQA1
0201, -DQB1*0303 haplotype. To investigate whether this haplotype ext
ends to include particular TAP2 and/or DP alleles, we tested the TAP2
and HLA-DP alleles of a control group (n = 133), patients with psorias
is type I (n = 66), and patients with psoriasis type II(n = 35) by hyb
ridization with SSOs. Out data show that there is no significant corre
lation between TAP2 and/or HLA-DP gene polymorphism and psoriasis type
I and/or type II. We conclude that disease association in type I psor
iasis is associated with the extended haplotype HLA-B57, -Cw6, -DRB10
701/2, -DQA10201, -DQB1*0303.